Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations

BACKGROUND AND AIMS: The first standard of care in treatment of chronic HCV genotype 1 infection involving directly acting antivirals was protease inhibitors telaprevir or boceprevir combined with pegylated-interferon and ribavirin (triple therapy). Phase III studies include highly selected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Sølund, Christina, Krarup, Henrik, Ramirez, Santseharay, Thielsen, Peter, Røge, Birgit T., Lunding, Suzanne, Barfod, Toke S., Madsen, Lone G., Tarp, Britta, Christensen, Peer B., Gerstoft, Jan, Laursen, Alex L., Bukh, Jens, Weis, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249835/
https://www.ncbi.nlm.nih.gov/pubmed/25438153
http://dx.doi.org/10.1371/journal.pone.0113034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4249835/
https://www.ncbi.nlm.nih.gov/pubmed/25438153
http://dx.doi.org/10.1371/journal.pone.0113034

Ejemplares similares